In AD [21]; Parkinson’s disease (PD) [22]; and Huntingdon’s disease (HD) [23]; over-activity of these serine/ threonine kinases or dysfunction in PP2A activity is linked with pathophysiology. This evidence concerns the gene MARK2 and Parkinson disease.